Zolmitriptan Tablet
Product Images NDC 27241-021

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 27241-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolmitriptan 2 5mg Foil

Blister card packaging label for Zolmitriptan tablets USP, each containing 2.5 mg of active ingredient. The label shows six tablet sections with barcodes and text stating "Protect from light and moisture." Manufactured by Ajanta Pharma Ltd., made in India. The label includes the NDC code, lot, and expiration area markings.*

FDA Label Image

Zolmitriptan 2 5mg

Packaging label for Zolmitriptan Tablets, USP, 2.5 mg, oral tablets. The carton indicates a package size of 6 tablets and includes the labeler Ajanta Pharma USA Inc. The design features the product name prominently with dosage strength in a green oval background, prescription only symbol, storage instructions, and a barcode. The label states that each coated tablet contains 2.5 mg of Zolmitriptan.*

FDA Label Image

Zolmitriptan 5mg Foil

Packaging label for Zolmitriptan tablet, USP, 5 mg strength. The label includes the brand name Zolmitriptan prominently, a barcode, and instructions to protect from light and moisture. It states the manufacturer as Ajanta Pharma Ltd., Made in India, with a code number MH/DRUGS/AD/018 and number 3023781. The label design repeats three times on the sheet.*

FDA Label Image

Zolmitriptan 5mg

Packaging label for Zolmitriptan Tablets, USP 5 mg, containing 3 tablets. The label shows the product name, strength, and dosage form prominently with the NDC 27241-022-38. It is marketed by Ajanta Pharma USA Inc. and indicates storage conditions and warnings regarding child safety and usage. The package is marked Rx Only.*

FDA Label Image

Figure_01 (Zolmitriptan Fig1)

A line graph showing the estimated probability of response over time from initial dose for Zolmitriptan tablets at 1 mg, 2.5 mg, and 5 mg doses compared to placebo. The x-axis represents time from initial dose (0 to 4 hours), and the y-axis shows the estimated probability of response as a percentage (0% to 100%). Multiple dose-response curves are plotted, indicating increased response probability over time.*

FDA Label Image

Zolmitriptan Fig 2

A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose, comparing placebo and zolmitriptan doses of 1 mg, 2.5 mg, and 5 mg. The x-axis represents time in hours, and the y-axis represents the estimated probability percentage.*

FDA Label Image

Structure (Zolmitriptan Str)

Chemical structure diagram of zolmitriptan, showing its molecular framework including indole and oxazolidinone components, along with dimethylaminopropyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.